CERTARA INC. - COMMON

Certara Reports Third Quarter 2022 Financial Results

07 11 2022 15:15:01 提供 Nasdaq GlobeNewswire

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

07 11 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

02 11 2022 16:00:00 提供 Nasdaq GlobeNewswire

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions

19 10 2022 07:00:02 提供 Nasdaq GlobeNewswire

Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022

13 10 2022 06:45:00 提供 Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

31 8 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara Announces Secondary Offering

11 8 2022 15:38:42 提供 Nasdaq GlobeNewswire

Certara Reports Second Quarter 2022 Financial Results

09 8 2022 15:15:01 提供 Nasdaq GlobeNewswire

Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module

05 8 2022 07:00:00 提供 Nasdaq GlobeNewswire

Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies

28 7 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara Appoints Rosemary Crane as New Independent Board Member

25 7 2022 07:00:00 提供 Nasdaq GlobeNewswire

Certara Appoints Eran Broshy as New Independent Board Member

13 7 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

12 7 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development

28 6 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics

21 6 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara Reports First Quarter 2022 Financial Results

05 5 2022 15:15:00 提供 Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

03 5 2022 15:30:00 提供 Nasdaq GlobeNewswire

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

20 4 2022 07:00:01 提供 Nasdaq GlobeNewswire

Certara Reports Fourth Quarter and Full Year 2021 Financial Results

01 3 2022 15:15:00 提供 Nasdaq GlobeNewswire

U.S. FDA Licenses Certara’s Immunogenicity Simulator

23 2 2022 15:30:00 提供 Nasdaq GlobeNewswire